Literature DB >> 2431541

Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1.

D C Jackson, X L Tang, L E Brown, J M Murray, D O White, G W Tregear.   

Abstract

A synthetic peptide comprising the C-terminal 24 amino acids of the heavy chain (HA1) of influenza virus hemagglutinin was constructed and examined for antigenic and immunogenic activity. Monoclonal antibodies as well as polyclonal antisera raised against the synthetic peptide were able to bind to intact virus. This binding was greatly enhanced if the virus was first subjected to pH 5, suggesting that this treatment exposes the C-terminus of HA1. Using synthetic analogs of the native sequence it was shown that the epitope recognized by one of the monoclonal antibodies encompasses one or more of the C-terminal four amino acids of HA1 (residues 325-328), which are conserved within subtypes but differ between subtypes, while the other monoclonal antibody recognizes a different epitope which involves at least one of the five variable residues at positions 311-315.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431541     DOI: 10.1016/0042-6822(86)90222-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.

Authors:  G Deliyannis; J S Boyle; J L Brady; L E Brown; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.

Authors:  Yuk-Fai Lau; Lay-Hoon Tang; Amber W McCall; Eng-Eong Ooi; Kanta Subbarao
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

4.  Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Authors:  R A Ffrench; X L Tang; E M Anders; D C Jackson; D O White; H Drummer; J D Wade; G W Tregear; L E Brown
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

Authors:  F Kostolansky; G Russ; V Mucha; B Styk
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Minimum requirements for immunogenic and antigenic activities of homologs of a synthetic peptide of influenza virus hemagglutinin.

Authors:  X L Tang; G W Tregear; D O White; D C Jackson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin.

Authors:  L E Brown; J M Murray; E M Anders; X L Tang; D O White; G W Tregear; D C Jackson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.

Authors:  Joanna C A Cobbin; Weiguang Zeng; David C Jackson; Lorena E Brown
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

9.  Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

Authors:  Miriam Klausberger; Rupert Tscheliessnig; Silke Neff; Raffael Nachbagauer; Teddy John Wohlbold; Monika Wilde; Dieter Palmberger; Florian Krammer; Alois Jungbauer; Reingard Grabherr
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

10.  In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential.

Authors:  José Esteban Muñoz-Medina; Carlos Javier Sánchez-Vallejo; Alfonso Méndez-Tenorio; Irma Eloísa Monroy-Muñoz; Javier Angeles-Martínez; Andrea Santos Coy-Arechavaleta; Clara Esperanza Santacruz-Tinoco; Joaquín González-Ibarra; Yu-Mei Anguiano-Hernández; César Raúl González-Bonilla; Eva Ramón-Gallegos; José Alberto Díaz-Quiñonez
Journal:  Biomed Res Int       Date:  2015-08-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.